Skip to content
Home
About
Contact
Menu
Home
About
Contact
Knowledge center
We share our knowledge
We share our knowledge
Scientific
publications
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond
Read more ⇢
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond
READ MORE ⇢
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond
READ MORE ⇢
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond
READ MORE ⇢
Media coverage
Interest grows in three experimental COVID-19 treatments
READ MORE ⇢
"Magični metak" - lek koji Srbija planira da nabavi u borbi protiv kovida
READ MORE ⇢
Israeli drug holds promise of stopping fatal Covid-19 immune response
READ MORE ⇢
El medicamento 'de Fierabrás' israelí que curaría el covid en 5 días
READ MORE ⇢
A fin de año estaría en uso revolucionario remedio israelí para Covid-19
READ MORE ⇢
O tratamento israelita que promete revolucionar o combate à covid-19
READ MORE ⇢
Lek iz Izraela navodno zaustavlja kovid za pet dana
READ MORE ⇢
COVID: 90% of patients treated with new Israeli drug discharged in 5 days
READ MORE ⇢
Media coverage
"Magični metak" - lek koji Srbija planira da nabavi u borbi protiv kovida
Read More ⇢
Interest grows in three experimental COVID-19 treatments
Read More ⇢
Israeli drug holds promise of stopping fatal Covid-19 immune response
Read More ⇢
El medicamento 'de Fierabrás' israelí que curaría el covid en 5 días
Read More ⇢
A fin de año estaría en uso revolucionario remedio israelí para Covid-19
Read More ⇢
O tratamento israelita que promete revolucionar o combate à covid-19
Read More ⇢
Lek iz Izraela navodno zaustavlja kovid za pet dana
Read More ⇢
COVID: 90% of patients treated with new Israeli drug discharged in 5 days
Read More ⇢
Show More
Other resources
Conference
Conference
WE ARE
FALLING
WALLS
FINALISTS
Conference
Conference
Conference
Conference
Conference
Conference